SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
3.190
-0.040 (-1.24%)
At close: Sep 18, 2025, 4:00 PM EDT
3.250
+0.060 (1.88%)
After-hours: Sep 18, 2025, 7:43 PM EDT
SOPHiA GENETICS Revenue
SOPHiA GENETICS had revenue of $18.32M in the quarter ending June 30, 2025, with 15.91% growth. This brings the company's revenue in the last twelve months to $69.69M, up 7.31% year-over-year. In the year 2024, SOPHiA GENETICS had annual revenue of $65.17M with 4.49% growth.
Revenue (ttm)
$69.69M
Revenue Growth
+7.31%
P/S Ratio
3.10
Revenue / Employee
$164,747
Employees
423
Market Cap
215.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 65.17M | 2.80M | 4.49% |
| Dec 31, 2023 | 62.37M | 14.81M | 31.14% |
| Dec 31, 2022 | 47.56M | 7.11M | 17.58% |
| Dec 31, 2021 | 40.45M | 12.05M | 42.43% |
| Dec 31, 2020 | 28.40M | 3.04M | 11.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
SOPH News
- 13 days ago - SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology - PRNewsWire
- 6 weeks ago - SOPHiA GENETICS SA (SOPH) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - SOPHiA GENETICS Reports Second Quarter 2025 Results - PRNewsWire
- 6 weeks ago - SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes - PRNewsWire
- 2 months ago - SOPHiA GENETICS to Announce Financial Results for Second Quarter 2025 on August 5, 2025 - PRNewsWire
- 4 months ago - SOPHiA GENETICS SA (SOPH) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - SOPHiA GENETICS Reports First Quarter 2025 Results - PRNewsWire
- 5 months ago - SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR - PRNewsWire